NCT07023432 2026-05-22Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)M.D. Anderson Cancer CenterPhase 2 Recruiting78 enrolled
NCT07593040 2026-05-20MoonlandingVall d'Hebron Institute of OncologyPhase 2 Not yet recruiting150 enrolled